Brief: Onxeo reports commercial court of Paris decision in lawsuit against SpeBio/SpePharm
Oct 17 (Reuters) - Onxeo Sa C4X.PA -
* Onxeo reports first instance decision from commercial
court of Paris in lawsuit against SpeBio/SpePharm
* Onxeo Sa -given 50% ownership of SpeBio B.V. by
Onxeo,financial liabilities between both cos,net financial
impact to Onxeo will have to be recalculated
* Onxeo Sa - Onxeo considered that SpePharm and SpeBio
breached their contractual obligations
Source text for Eikon: ID:nGNXOEZJYa
Further company coverage: C4X.PA
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Valerio Therapeutics SA
See all newsBrief: Valerio Therapeutics To Buy Etherna Immunotherapies For €30 Mln
Brief: Valerio Therapeutics Signs Development Collaboration With Abivax
Brief: Valerio Therapeutics Enters Into Collaboration & Exclusive License With Seed-Stage Biotech Co
Brief: Onxeo Changes Its Name And Becomes Valerio Therapeutics
Brief: Onxeo H1 Net Loss Widens To EUR 11.5 Mln